Most Recent Reported Fiscal Year Budget
In FY 2021, Congress passed a consolidated appropriations act allocating $6.365 billion to NCI, including $50 million for the Childhood Cancer Data Initiative (CCDI) and $28 million for Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act. NCI was also appropriated $195 million in FY 2021 as a result of the 21st Century Cures Act. After permissive transfers, $6.467 billion was available to NCI to obligate.
In addition to the appropriated amount for the fiscal year, NCI entered into inter- and intra-agency agreements with other Federal agencies and NIH institutes and centers (ICs). These agreements often provide reimbursements for materials, supplies, equipment, work, or services to assist other agencies and ICs accomplish their missions.
| Actual Obligations Resulting From Appropriated Funds | FY 2020 Amount |
|---|---|
| FY 2021 Appropriation | $6,364,852,000 |
| FY 2021 Cancer Moonshot Appropriation | $195,000,000 |
|
Secretary's Transfer |
-$19,109,000 |
|
Transfer to NIH Office of AIDS Research |
-$1,047,000 |
| Lapse | -$289,223 |
| Cancer Moonshot Carryover | -$96,671,541 |
| Actual Obligations Subtotal | $6,442,735,236 |
| Reimbursable Obligations | $24,294,730 |
| Total FY 2021 NCI Obligations | $6,467,029,966 |
Includes FY 2021 Cures Moonshot funding and excludes FYs 2020 through 2017 Cures Moonshot carryover obligations.